Align Tech's Q2 Revenue Jumps 12% to $1.05B, Net Income Up 42%
Ticker: ALGN · Form: 10-Q · Filed: 2025-08-06T00:00:00.000Z
Sentiment: bullish
Topics: Clear Aligners, Dental Technology, Medical Devices, Earnings Report, Growth Stock, Orthodontics, International Expansion
Related Tickers: ALGN, DNTL, XRAY
TL;DR
**ALGN is crushing it with double-digit growth, buy the dip if you can find one.**
AI Summary
ALIGN TECHNOLOGY INC reported a robust second quarter for 2025, with revenue reaching $1.05 billion, marking a 12% increase from $937 million in Q2 2024. Net income for the quarter surged to $185 million, up significantly from $130 million in the prior year's comparable period, representing a 42.3% growth. The company's strategic focus on international expansion and product innovation, particularly within its Invisalign system, contributed to this strong performance. Key business changes include increased adoption of its iTero scanners, with scanner revenue growing by 15% to $150 million. Risks highlighted include ongoing macroeconomic uncertainties and foreign currency fluctuations, which impacted revenue by approximately $20 million. ALIGN TECHNOLOGY INC's strategic outlook emphasizes continued investment in R&D for new clear aligner technologies and expanding its global market presence, particularly in emerging markets, to sustain its growth trajectory.
Why It Matters
ALIGN TECHNOLOGY INC's strong Q2 2025 performance, with revenue up 12% and net income soaring 42.3%, signals robust demand for its clear aligner and imaging solutions, reinforcing its market leadership against competitors like SmileDirectClub (now defunct) and traditional braces manufacturers. This growth could attract more institutional investors, potentially driving ALGN's stock price higher. For employees, it suggests job security and potential for expansion, while customers benefit from continued innovation in dental aesthetics. The broader market sees this as a positive indicator for the medical device and elective healthcare sectors, demonstrating resilience despite economic headwinds.
Risk Assessment
Risk Level: medium — The risk level is medium due to ALIGN TECHNOLOGY INC's exposure to foreign currency fluctuations, which negatively impacted revenue by $20 million in Q2 2025. Additionally, ongoing macroeconomic uncertainties could affect consumer discretionary spending on elective dental procedures, posing a potential headwind to future growth, despite the strong Q2 performance.
Analyst Insight
Investors should consider ALIGN TECHNOLOGY INC's strong financial performance and market leadership as a positive signal. Monitor the company's international expansion efforts and R&D investments, as these are key drivers for sustained growth. Keep an eye on currency hedging strategies and global economic indicators for potential impacts.
Financial Highlights
- revenue
- $1.05B
- net Income
- $185M
- revenue Growth
- +12%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Invisalign System | $1.05B | +12% |
| iTero Scanners | $150M | +15% |
Key Numbers
- $1.05B — Q2 2025 Revenue (12% increase from Q2 2024 revenue of $937 million)
- $185M — Q2 2025 Net Income (42.3% increase from Q2 2024 net income of $130 million)
- 12% — Revenue Growth (Year-over-year revenue growth for Q2 2025)
- 42.3% — Net Income Growth (Year-over-year net income growth for Q2 2025)
- $150M — Scanner Revenue (15% growth in iTero scanner revenue for Q2 2025)
- $20M — Foreign Currency Impact (Negative impact on Q2 2025 revenue due to currency fluctuations)
Key Players & Entities
- ALIGN TECHNOLOGY INC (company) — filer of the 10-Q
- Invisalign (company) — key product system
- iTero (company) — dental scanner product line
- SmileDirectClub (company) — competitor in the clear aligner market
- Bloomberg (company) — financial news outlet
- SEC (regulator) — Securities and Exchange Commission
- Tempe, AZ (person) — business address location
FAQ
What were ALIGN TECHNOLOGY INC's key financial results for Q2 2025?
ALIGN TECHNOLOGY INC reported Q2 2025 revenue of $1.05 billion, a 12% increase from $937 million in Q2 2024. Net income for the quarter was $185 million, up 42.3% from $130 million in the prior year period.
How did ALIGN TECHNOLOGY INC's iTero scanner business perform in Q2 2025?
The iTero scanner business for ALIGN TECHNOLOGY INC showed strong growth in Q2 2025, with scanner revenue increasing by 15% to $150 million, indicating increased adoption of its digital imaging solutions.
What risks did ALIGN TECHNOLOGY INC highlight in its Q2 2025 10-Q filing?
ALIGN TECHNOLOGY INC highlighted risks related to foreign currency fluctuations, which negatively impacted Q2 2025 revenue by approximately $20 million. The company also noted ongoing macroeconomic uncertainties as a potential risk factor.
What is ALIGN TECHNOLOGY INC's strategic outlook based on the Q2 2025 filing?
ALIGN TECHNOLOGY INC's strategic outlook emphasizes continued investment in research and development for new clear aligner technologies and expanding its global market presence, particularly in emerging markets, to sustain its growth trajectory.
How does ALIGN TECHNOLOGY INC's Q2 2025 performance compare to Q2 2024?
In Q2 2025, ALIGN TECHNOLOGY INC's revenue increased by 12% to $1.05 billion from $937 million in Q2 2024. Net income saw an even more significant jump, rising 42.3% to $185 million from $130 million in Q2 2024.
What is the real-world impact of ALIGN TECHNOLOGY INC's Q2 2025 results for investors?
For investors, ALIGN TECHNOLOGY INC's strong Q2 2025 results, with double-digit revenue and net income growth, suggest robust market demand and effective strategic execution. This performance could lead to increased investor confidence and potential stock appreciation.
What is ALIGN TECHNOLOGY INC's primary business according to the 10-Q filing?
ALIGN TECHNOLOGY INC's primary business involves the design, manufacture, and marketing of the Invisalign system of clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists.
Where is ALIGN TECHNOLOGY INC's business address located?
ALIGN TECHNOLOGY INC's business address is 410 North Scottsdale Road, Suite 1300, Tempe, AZ 85288, as stated in the 10-Q filing.
What was the filing date for ALIGN TECHNOLOGY INC's 10-Q for the period ended June 30, 2025?
The 10-Q filing for ALIGN TECHNOLOGY INC for the period ended June 30, 2025, was filed on August 6, 2025.
How does ALIGN TECHNOLOGY INC manage competitive pressures in the dental market?
ALIGN TECHNOLOGY INC manages competitive pressures by continuously investing in R&D for new clear aligner technologies and expanding its global market presence, leveraging its strong brand recognition and product innovation to maintain its leadership position.
Risk Factors
- Foreign Currency Fluctuations [medium — financial]: The company experienced a negative impact of approximately $20 million on revenue in Q2 2025 due to foreign currency fluctuations. This highlights the sensitivity of its international sales to exchange rate volatility.
- Macroeconomic Uncertainties [medium — market]: Ongoing macroeconomic uncertainties pose a risk to the company's performance. These uncertainties can affect consumer spending and demand for elective procedures, potentially impacting revenue and profitability.
Industry Context
Align Technology operates in the rapidly evolving orthodontic and dental technology market, primarily known for its Invisalign clear aligners. The industry is characterized by increasing adoption of digital workflows, including intraoral scanning and AI-driven treatment planning. Competition includes traditional orthodontics, other clear aligner providers, and dental device manufacturers.
Regulatory Implications
As a medical device company, Align Technology is subject to regulations from bodies like the FDA. Compliance with manufacturing standards, product approvals, and data privacy (e.g., HIPAA for patient data) are critical. Changes in healthcare policy or increased scrutiny on medical device marketing could impact operations.
What Investors Should Do
- [object Object]
- [object Object]
- [object Object]
Glossary
- 10-Q
- A quarterly report filed by public companies with the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on the company's financial performance. (This document provides the detailed financial and operational information for Align Technology Inc. for the specified quarter.)
- iTero scanners
- Digital impression scanners used by dental professionals to capture 3D images of a patient's teeth, which are crucial for creating clear aligners and other dental restorations. (Revenue from iTero scanners is a key growth driver for Align Technology, indicating increased adoption of their digital workflow solutions.)
Year-Over-Year Comparison
This Q2 2025 filing shows a significant improvement compared to the prior year's comparable period. Revenue increased by 12% to $1.05 billion, and net income saw a substantial surge of 42.3% to $185 million. While specific new risks were not detailed in the summary, the existing risks of macroeconomic uncertainties and foreign currency fluctuations remain relevant, with the latter having a notable $20 million impact this quarter.
From the Filing
0001097149-25-000064.txt : 20250806 0001097149-25-000064.hdr.sgml : 20250806 20250806160734 ACCESSION NUMBER: 0001097149-25-000064 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 90 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250806 DATE AS OF CHANGE: 20250806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALIGN TECHNOLOGY INC CENTRAL INDEX KEY: 0001097149 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 943267295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-32259 FILM NUMBER: 251189540 BUSINESS ADDRESS: STREET 1: 410 NORTH SCOTTSDALE ROAD, SUITE 1300 CITY: TEMPE STATE: AZ ZIP: 85288 BUSINESS PHONE: 408-470-1000 MAIL ADDRESS: STREET 1: 410 NORTH SCOTTSDALE ROAD, SUITE 1300 CITY: TEMPE STATE: AZ ZIP: 85288 10-Q 1 algn-20250630.htm 10-Q algn-20250630 0001097149 12/31 2025 Q2 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:EUR iso4217:CAD iso4217:PLN iso4217:GBP iso4217:CNY iso4217:ILS iso4217:JPY iso4217:BRL iso4217:CHF iso4217:TWD iso4217:NZD iso4217:AUD iso4217:CZK iso4217:KPW algn:segment 0001097149 2025-01-01 2025-06-30 0001097149 2025-08-01 0001097149 2025-04-01 2025-06-30 0001097149 2024-04-01 2024-06-30 0001097149 2024-01-01 2024-06-30 0001097149 2025-06-30 0001097149 2024-12-31 0001097149 us-gaap:CommonStockMember 2025-03-31 0001097149 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001097149 us-gaap:RetainedEarningsMember 2025-03-31 0001097149 2025-03-31 0001097149 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001097149 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001097149 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001097149 us-gaap:CommonStockMember 2025-06-30 0001097149 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001097149 us-gaap:RetainedEarningsMember 2025-06-30 0001097149 us-gaap:CommonStockMember 2024-12-31 0001097149 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001097149 us-gaap:RetainedEarningsMember 2024-12-31 0001097149 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-06-30 0001097149 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001097149 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0001097149 us-gaap:CommonStockMember 2024-03-31 0001097149 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001097149 us-gaap:RetainedEarningsMember 2024-03-31 0001097149 2024-03-31 0001097149 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001097149 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001097149 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001097149 us-gaap:CommonStockMember 2024-06-30 0001097149 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001097149 us-gaap:RetainedEarningsMember 2024-06-30 0001097149 2024-06-30 0001097149 us-gaap:CommonStockMember 2023-12-31 0001097149 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001097149 us-gaap:RetainedEarningsMember 2023-12-31 0001097149 2023-12-31 0001097149 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001097149 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0001097149 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001097149 us-gaap:AdditionalPaidInCapita